Fortress Biotech, Inc. (FBIOP) Capital expenditures 2016–2024
Fortress Biotech, Inc. (FBIOP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2024 · since FY2016: $6.4M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $63,000 | -97.7% |
| FY2022 | $2.7M | -40.5% |
| FY2021 | $4.6M | +137.1% |
| FY2020 | $1.9M | -17.9% |
| FY2019 | $2.3M | -66.9% |
| FY2018 | $7.1M | +992.9% |
| FY2017 | $648,000 | -89.8% |
| FY2016 | $6.4M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIOP financial trends
FBIOP RevenueFBIOP Net incomeFBIOP Net marginFBIOP Gross profitFBIOP Gross marginFBIOP Operating incomeFBIOP Operating marginFBIOP Operating cash flowFBIOP Free cash flowFBIOP Return on equityFBIOP Stock buybacksFBIOP Dividends paidFBIOP Total assetsFBIOP Total liabilitiesFBIOP Shareholders’ equityFBIOP overview →